Table 3 Enhancement of Mitogenic Activity of Human VSMC by Products of Hydrolysis of Lipoproteins
Agent | n | Control cpm/well | Agent cpm/well | p |
|---|---|---|---|---|
Lyso PtdChol (20 μm) | 5 | 3233 ± 587 | 5296 ± 1054 | <.05 |
(30 μm) | 2 | 3019 ± 516 | 5766 ± 858 | <.01 |
Linoleic acid (10 μm) | 5 | 3389 ± 683 | 5358 ± 680 | <.01 |
(20 μm) | 3 | 3895 ± 468 | 4922 ± 813 | <.05 |
Oleic acid (10 μm) | 2 | 3410 ± 755 | 7001 ± 1500 | <.01 |
(20 μm) | 2 | 4216 ± 312 | 7271 ± 814 | <.01 |
(30 μm) | 3 | 3565 ± 729 | 9451 ± 2589 | <.01 |
Lyso PtdChol + linoleic acid (20 μm) + (10 μm) | 3 | 3464 ± 750 | 7837 ± 1254 | <.01 |
Lyso PtdChol + oleic acid (20 μm) + (10 μm) | 3 | 3464 ± 750 | 10411 ± 1638 | <.01 |